Gerri Baer

476 total citations
13 papers, 273 citations indexed

About

Gerri Baer is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gerri Baer has authored 13 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gerri Baer's work include Pharmaceutical studies and practices (11 papers), Neonatal Respiratory Health Research (6 papers) and Pediatric Pain Management Techniques (4 papers). Gerri Baer is often cited by papers focused on Pharmaceutical studies and practices (11 papers), Neonatal Respiratory Health Research (6 papers) and Pediatric Pain Management Techniques (4 papers). Gerri Baer collaborates with scholars based in United States, United Kingdom and Netherlands. Gerri Baer's co-authors include Gilbert J. Burckart, Karel Allegaert, Susan McCune, Robert M. Nelson, M. Turner, Robert M. Ward, John N. van den Anker, William Slikker, Connie L. Chen and Kevin Krudys and has published in prestigious journals such as PEDIATRICS, American Journal of Obstetrics and Gynecology and The Journal of Pediatrics.

In The Last Decade

Gerri Baer

13 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerri Baer United States	9	140	59	45	42	26	13	273
Anil R. Maharaj United States	10	99 0.7×	27 0.5×	36 0.8×	71 1.7×	27 1.0×	33	277
Jumpei Saito Japan	13	137 1.0×	19 0.3×	79 1.8×	80 1.9×	55 2.1×	62	399
Punam Mistry United Kingdom	8	140 1.0×	29 0.5×	13 0.3×	10 0.2×	11 0.4×	9	259
Abdur Rasheed Pakistan	13	59 0.4×	63 1.1×	37 0.8×	17 0.4×	39 1.5×	42	440
Mojca Kerec Kos Slovenia	10	52 0.4×	31 0.5×	15 0.3×	47 1.1×	36 1.4×	25	328
Akimasa Yamatani Japan	12	100 0.7×	9 0.2×	77 1.7×	54 1.3×	12 0.5×	50	303
Geert ‘t Jong Canada	6	120 0.9×	23 0.4×	42 0.9×	16 0.4×	39 1.5×	16	246
Jean Vigneron France	9	117 0.8×	22 0.4×	15 0.3×	97 2.3×	80 3.1×	51	405
Kathryn Drennan United States	9	99 0.7×	27 0.5×	61 1.4×	33 0.8×	9 0.3×	26	266

Countries citing papers authored by Gerri Baer

Since Specialization

Citations

This map shows the geographic impact of Gerri Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerri Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerri Baer more than expected).

Fields of papers citing papers by Gerri Baer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerri Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerri Baer. The network helps show where Gerri Baer may publish in the future.

Co-authorship network of co-authors of Gerri Baer

This figure shows the co-authorship network connecting the top 25 collaborators of Gerri Baer. A scholar is included among the top collaborators of Gerri Baer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerri Baer. Gerri Baer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Massaro, An N., et al.. (2025). A Pediatric Research Imperative: Addressing Neonates in Drug Development Through Understanding Neonatal Clinical Pharmacology. The Journal of Pediatric Pharmacology and Therapeutics. 30(1). 8–16. 1 indexed citations

Sewell, Catherine, Leslie Meltzer Henry, Christina Bucci‐Rechtweg, et al.. (2022). Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials. American Journal of Obstetrics and Gynecology. 227(6). 805–811. 32 indexed citations

Sharma, Isha, et al.. (2021). Prospect of Direct Benefit in Pediatric Trials: Practical Challenges and Potential Solutions. PEDIATRICS. 147(5). 10 indexed citations

Baer, Gerri, Robert Lim, Elektra J. Papadopoulos, et al.. (2020). Advancing Therapeutic Development for Pulmonary Morbidities Associated with Preterm Birth. Therapeutic Innovation & Regulatory Science. 54(6). 1312–1318. 2 indexed citations

Anker, John N. van den, Susan McCune, Pieter Annaert, et al.. (2020). Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs. Pharmaceutics. 12(7). 685–685. 79 indexed citations

Salaets, Thomas, M. Turner, Mary B. Short, et al.. (2019). Development of a neonatal adverse event severity scale through a Delphi consensus approach. Archives of Disease in Childhood. 104(12). 1167–1173. 40 indexed citations

Davis, Jonathan M., Gerri Baer, Susan McCune, et al.. (2019). Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials. The Journal of Pediatrics. 219. 243–249.e1. 14 indexed citations

Wang, Jian, Shaun S. Kumar, Catherine M.T. Sherwin, et al.. (2018). Renal Clearance in Newborns and Infants: Predictive Performance of Population‐Based Modeling for Drug Development. Clinical Pharmacology & Therapeutics. 105(6). 1462–1470. 32 indexed citations

Davis, Jonathan M., Gerri Baer, Ronald J. Portman, et al.. (2017). Enrollment of Neonates in More Than One Clinical Trial. Clinical Therapeutics. 39(10). 1959–1969. 11 indexed citations

10.

Buckley, Lorrene A., Smita Salunke, Karen Thompson, et al.. (2017). Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients. International Journal of Pharmaceutics. 536(2). 563–569. 29 indexed citations

11.

Avant, Debbie, Gerri Baer, Alfred Sorbello, et al.. (2017). Neonatal Safety Information Reported to the FDA During Drug Development Studies. Therapeutic Innovation & Regulatory Science. 52(1). 100–108. 6 indexed citations

12.

McCune, Susan, Yeruk Mulugeta, & Gerri Baer. (2017). Collaboration in Regulatory Science to Facilitate Therapeutic Development for Neonates. Current Pharmaceutical Design. 23(38). 5801–5804. 1 indexed citations

13.

Baer, Gerri & Robert M. Nelson. (2006). Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative. Clinical Therapeutics. 28(9). 1399–1407. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact